Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
Вставка
- Опубліковано 27 вер 2024
- Dr Tuttle presents a recent evaluation of the safety of empagliflozin in in patients with both type 2 diabetes and chronic kidney disease.
Subscribe: www.youtube.co...
Visit The Video Journal of Biomedicine: www.biomedicin...
Follow us on Twitter: / vjofbiomedicine
LinkedIn: / video-journal-of-biome...
Facebook: / videojournalbiomedicine
#t2d #t2dm #ckd #empagliflozin #SGLT2i #diabetes #kidneydisease #chronickidneydisease